Here, the focus is on studying the genetics of diseases that particularly afflict the Chinese population, such as hepatocellular carcinoma, a form of liver cancer.

ECONOMIST: Chinese biotechnology

In this case, two young scientists, Holger Willenbring and Xin Chen, were trying to study a deadly, and fairly common, form of liver cancer called hepatocellular carcinoma.

FORBES: Cells Get a Makeover, Cancer Follows: A Path to New Therapies (and a Warning to Stem Cell Alchemists)